Cormedix Inc (NAS:CRMD)
$ 5.12 0.01 (0.2%) Market Cap: 281.39 Mil Enterprise Value: 223.47 Mil PE Ratio: 0 PB Ratio: 4.85 GF Score: 54/100

Q3 2023 CorMedix Inc Earnings Call Transcript

Nov 14, 2023 / 09:30PM GMT
Release Date Price: $3.13 (+0.64%)
Operator

Good afternoon, and welcome to CorMedix third-quarter 2023 earnings conference call. Today's call is being recorded. (Operator Instructions)

At this time, I would like to turn the conference over to Dan Ferry from LifeSci Advisors. Please go ahead.

Dan Ferry
Lifesci Advisors, LLC - IR

Good afternoon, and welcome to the CorMedix third-quarter 2023 earnings conference call. Leading the call today is Joe Todisco, Chief Executive Officer of CorMedix; and he is joined by Dr. Matt David, Executive Vice President and CFO; Dr. Phoebe Mounts, EVP and General Counsel; and Erin Mistry, EVP and Chief Commercial Officer.

Before we begin, I would like to remind everyone that during the call, management may make what are known as forward-looking statements within the meaning set forth in the Private Securities Litigation Reform Act of 1995. These statements are subject to certain risks and uncertainties that include, but are not limited to, any of the following: any statements other than statements of historical fact regarding management's expectations,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot